Alzamend Neuro, Inc. ALZN 深 沪
等待开盘 03-27 09:30:00 美东时间
1.50
-0.430
-22.28%
华盛通- 最 高1.91
- 今 开1.84
- 成交量 221.15万股
- 最 低 1.46
- 昨 收 1.93
- 总市值 570.71万
- 52周最高 8.82
- 市盈率 静 --
- 换手率 58.13%
- 52周最低 1.46
- 委 比 78.95%
- 总股本 380.47万
- 历史最高 45292.50
- 量 比 30.06
- 振 幅 23.32%
- 历史最低 1.46
- 每 手 1
- 风险率 1.72%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Alzamend Announces Topline Data From First Phase II "Lithium In Brain" Clinical Trial, Demonstrating AL001 Meets Bioequivalence Standards, And Showing Numerically Superior Lithium Delivery To Brain Compared To Standard Lithium Carbonate
Bioequivalence Confirmed: AL001 delivered 101% of total lithium blood exposure and 97% of peak lithium levels vs. standard lithium carbonateSuperior Brain Penetration: AL001 showed numerically higher lithium
03-26 20:08
Alzamend Neuro Starts Phase II Clinical Study Of AL001 In Participants With Bipolar Disorder Type 1; Topline Data Anticipated By March End
Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disorder ("BD"), major
03-16 20:12
Alzamend Neuro Establishes ATM Equity Offering Agreement
Alzamend Neuro ( ($ALZN) ) has issued an update. On March 6, 2026, Alzamend Neu...
03-07 06:16
Alzamend Neuro Enters ATM Sales Agreement To Sell Up To $3.0M In Common Stock
-SEC Filing
03-07 05:48
10 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Icecure Medical (NASDAQ:ICCM) shares moved upwards by 17.7% to $0.68 d...
03-02 20:05
Alzamend Neuro Inc. Announces Date for 2026 Annual Meeting of Stockholders
Alzamend Neuro Inc. Announces Date for 2026 Annual Meeting of Stockholders Alzamend Neuro Inc. will hold its 2026 Annual Meeting of Stockholders on April 17, 2026. During the meeting, shareholders will vote on several key proposals, including the election of seven directors, the ratification of the
02-10 05:31
Alzamend Neuro gibt Termin für Hauptversammlung bekannt
Alzamend Neuro gibt Termin für Hauptversammlung bekannt Alzamend Neuro Inc. wird am 17. April 2026 eine Hauptversammlung abhalten. Auf der Tagesordnung steht unter anderem die Wahl der Direktoren. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intel
02-10 05:31
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers MoonLake (NASDAQ:MLTX) stock rose 8.2% to $20.0 during Friday's after-...
01-10 05:05
美股大行评级 | 潜在涨幅498.16%！SurgePays Inc获Ascendiant Capital升目标价至9.75美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持SurgePays Inc"买入"评级，目标价从9.5美元升至9.75美元；Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从8美元升至10美元
2025-12-23 12:32
Ascendiant Capital Maintains Buy on Alzamend Neuro, Lowers Price Target to $28
Ascendiant Capital analyst Edward Woo maintains Alzamend Neuro (NASDAQ:ALZN) with a Buy and lowers the price target from $42 to $28.
2025-12-22 20:15
